MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

488355

Report Date :

27.01.2018

 

IDENTIFICATION DETAILS

 

Name :

MANKIND PHARMA LIMITED

 

 

Formerly Known As :

MANKIND PHARMA PRIVATE LIMITED

 

 

Registered Office :

208, Okhla Industrial Estate, Phase – III, New Delhi-110020

Tel. No.:

91-11-46541111

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

03.07.1991

 

 

Com. Reg. No.:

55-044843

 

 

Capital Investment / Paid-up Capital :

INR 200.294 Million

 

 

CIN No.:

[Company Identification No.]

U74899DL1991PLC044843

 

 

IEC No.:

0593044312

 

 

GST No.:

07AAACM9401C1ZX

 

 

TIN No.:

07290281758

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACM9401C

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturing, Marketing and Trading of Pharmaceutical and Health Care Products. [Registered Activity]

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 59045300

 

 

Status :

Excellent

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Mankind Pharma Limited was incorporated in the year 1991. It is engaged in trading and manufacturing of pharmaceuticals and health care products.

 

For the financial year 2016, the company has achieved a YOY growth of 17.41% (Approximately) and has achieved a Good Net Profit margin of 14.90% (Approximately).

 

The robust financial profile of the company is marked by healthy networth base along with strong debt coverage indicators due to debt free balance sheet profile.

 

The company has given an output of Rupees 234.25 in the EPS section as compared to its original face value of Rupees 10.

 

Rating also derives strength from company’s established track record of business.

 

However, rating strengths are partially offset by unfavouarble gap between trade payables and trade receivables.

 

Business is active. Payment terms are reported to be regular.

 

In view of aforesaid, the company can be considered normal for business dealings at usual trade terms and conditions.

 

Note: As per Registrar of Companies, the date of balance sheet i.e financials filed is shown as 31st March, 2017 but documents related to the financials for the year 2017 are not available from any sources.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 27.01.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DECLINED

 

MANAGEMENT NON-COOPERATIVE

 

(Contact No: 91-11-46541375)

 

 

LOCATIONS

 

Registered Office :

208, Okhla Industrial Estate, Phase – III, New Delhi-110020, India

Tel. No.:

91-11-46541111/ 46541375 (30 Lines)

Fax No.:

91-11-46541382

E-Mail :

sanjeev.singh@mankindpharma.com

pradeep.chugh@makindpharma.com

finance@mankindpharma.com

contact@mankindpharma.com

businessdevelopment@mankindpharma.com

tender@mankindpharma.com

Website :

https://www.mankindpharma.com

 

 

Corporate Office :

236, Okhla Industrial Estate, Phase – III, New Delhi – 110020, India

Tel. No.:

91-11-46546060/ 46541400

 

 

Factory 1 :

Poanta Sahib (Himachal Pradesh), India

 

 

Factory 2 :

Plot No. 191 E, Sector 4, IMT Manesevar, Gurguram, Haryana, India

 

 

DIRECTORS

 

AS ON 31.03.2017        

 

Name :

Mr. Ramesh Chand Juneja

Designation :

Whole Time Director

Address :

B-7, Vasant Marg, 2nd Floor, Vasant Vihar, New Delhi - 110057, India

Date of Birth/Age :

18.07.1950

Date of Appointment :

15.05.2014

PAN No.:

AEJPJ9773L

DIN No.:

00283399

 

 

Name :

Mr. Rajeev Juneja

Designation :

Whole-time director

Address :

F-42, Radhey Mohan Drive, Jonapur, Mehrauli, New Delhi, India

Date of Birth/Age :

28.07.1965

Date of Appointment :

22.12.1992

PAN No.:

ADIPJ0332M

DIN No.:

00283481

 

 

Name :

Mr. Prem Kumar Arora

Designation :

Whole-time director

Address :

A-1/9, Vasant Vihar, New Delhi-110052, India

Date of Birth/Age :

11.09.1938

Date of Appointment :

01.05.2006

DIN No.:

00704226

 

 

Name :

Mrs. Sheetal Arora

Designation :

Managing Director

Address :

A-1/9, Vasant Vihar, New Delhi-110052, India

Date of Birth/Age :

18.11.1975

PAN No.:

ADPPA2599C

Date of Appointment :

21.09.2007

DIN No.:

00704292

 

 

Name :

Mr. Arjun Juneja

Designation :

Whole-time director

Address :

B-7, Vasant Marg, 2nd Floor, Vasant Vihar, New Delhi-110057, India

Date of Birth/Age :

09.05.1986

Date of Appointment :

15.05.2009

PAN No.:

AGEPJ3227A

DIN No.:

00704349

 

 

Name :

Mr. Surendra Lunia

Designation :

Director

Address :

5010, Phase –IV, DLF, Gurgaon – 122011, Haryana, India

Date of Appointment :

19.02.2015

DIN No.:

00121156

 

 

Name :

Ms. Prabha Arora

Designation :

Director

Address :

A-1/9, Vasant Vihar, New Delhi - 110052, India

Date of Birth/Age :

07.07.1948

Date of Appointment :

06.02.1995

PAN No.:

ADPPA3875K

DIN No.:

00283527

 

 

Name :

Mr. Sandip Sharma

Designation :

Director

Address :

27 Oak Drive Dlf, Kh No- 1137, 1139 DLF, Chhatterpur-110030, Delhi, India

Date of Appointment :

19.02.2015

DIN No.:

03248306

 

 

Name :

Mr. Anuj Girotra

Designation :

Alternate Director

Address :

53 Grange Road, #06-04, Spring Grove, Singapore 249565 Singapore

Date of Appointment :

05.03.2016

DIN No.:

06401549

 

 

Name :

Mr. Leonard Lee Kim

Designation :

Director

Address :

9, Ardmore Park, #15-01 Singapore 259955, Singapore

Date of Appointment :

14.03.2016

DIN No.:

07379167

 

 

Name :

Mr. Satish Kumar Sharma

Designation :

Wholetime Director

Address :

Vill. Po Duloth Jat, Distt. Mohindergarh-123021, Haryana, India

Date of Appointment :

23.09.2016

DIN No.:

07615602

 

 

KEY EXECUTIVES

 

Name :

Mr. Rajeev Juneja

Designation :

Chief Executive Officer (KMP)

Address :

F-42, Radhey Mohan Drive, Jonapur, Mehrauli, New Delhi, India

Date of Appointment :

15.05.2014

PAN No.:

ADIPJ0332M

 

 

Name :

Mr. Pradeep Chugh

Designation :

Company Secretary

Address :

94, 2nd Floor, Near Xion International School Sector 5, Part 3, Gurgaon-122001, Haryana, India

Date of Appointment :

23.09.2016

PAN No.:

AFVPC8199Q

 

 

Name :

Mr. Ashutosh Kumar Dhawan

Designation :

Chief Financial Officer (KMP)

Address :

7036, Sector - B, Pocket – 10, Vasant Kunj, New Delhi-110070, India

Date of Appointment :

17.06.2016

PAN No.:

AADPD2236J

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 31.03.2017

 

Names of Shareholders

No. of Shares

 

Percentage of Holding

Ramesh Juneja

588

0.00

Rajeev Juneja

4225899

21.10

Sheetal Arora

2494088

12.45

Arjun Juneja

859247

4.29

Prem Kumar Arora

3156

0.02

Poonam Juneja

5692378

28.42

Prabha Arora

2494088

12.45

Puja Juneja

2056741

10.27

Cairnhill CIPEF Limited

1914612

9.56

Cairnhill CGPE Limited

288625

1.44

 

 

 

Total

20029422

100.00

 

 

AS ON 23.09.2017

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters – Individual/Hindu Undivided Family (Indian)

89.00

Public/ Other than Promoters – Body Corporate

11.00

 

 

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing, Marketing and Trading of Pharmaceutical and Health Care Products. [Registered Activity]

 

 

Products/ Services :

ITC Code No.

 

Product/ Service Descriptions

98041000

Drugs and Medicines

 

 

Brand Names :

‘’Mankind’’

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

---

Contact Number:

---

Since how long known:

---

Maximum limit dealt:

---

Experience:

---

Remark

---

 

 

Customers :

Reference:

Not Divulged

Name of the Person (Designation):

---

Contact Number:

---

Since how long known:

---

Maximum limit dealt:

---

Experience:

---

Remark

---

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

·         ICICI Bank Limited

Landmarkrace Cource Circle, Alkapuri, Baroda - 390015, Gujarat, India

 

·         Citibank N.A

Jeevan Bharti Building, 4th Floor, 124, Connaught Circus, Connaught Place, New Delhi - 110001, India

 

·         HDFC Bank Limited

 

 

Facilities :

SECURED LOANS

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

LONG-TERM BORROWINGS

 

 

Loans taken for vehicles

0.000

0.178

 

 

 

Total

0.000

0.178

 

Financial Institution :

·         Citicorp Finance (India) Limited

 

 

Auditors 1 :

 

Name :

Bhagi Bhardwaj Gaur and Company

Chartered Accountants

Address :

2952-53/2, Sangtrashan, D.B Gupta Road, Paharganj, New Delhi-110055, India

Income-tax PAN of auditor or auditor's firm :

AADFB8409K

 

 

Auditors 2 :

 

Name :

Deloitte Haskins and Sells LLP

Chartered Accountants

Address :

7th Floor, Building - 10, Tower B, DLF Cyber City Complex, DLF City Phase-II, Gurgaon –122002, Haryana, India

Income-tax PAN of auditor or auditor's firm :

AACFD4815A

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiary Companies :

·         Life Star Pharma Limited, India (U24232DL2004PTC131232)

·         Magnet Labs Private Limited, India (U51397DL1998PTC093307)

·         Medi Pack Innovations Private Limited, India (U28113DL2012PTC237207)

·         Akasia Magnum Hospitality Private Limited, India [U55101HR2003PTC035032]

·         Appian Associates Infrastructure Private Limited, India [U45201HR2006PTC052011]

·         Jaspack Industries Private Limited, India [U36912DL2015PTC277915]

·         Mahananda Spa and Resorts Private Limited, India [U55101UR2009PTC032889]

·         Mithras Translogic Private Limited, India [U60200DL1991PTC043980]

·         Packtime Innovations Private Limited, India [U36912DL2015PTC281265]

·         Prolijune Life Sciences Private Limited, India

·         (U51500DL2006PTC153155)

·         Shree Jee Laboratory Private Limited, India [U24232DL2011PTC272907]

·         Broadway Hospitality Services Private Limited, India [U85110DL2003PTC123280]

·         Pavi Buildwell Private LimiteD, India [U70200DL2012PTC237294]

·         Gyan Infrastructure Company Private Limited, India [U70101DL1997PTC085909]

·         Lifestar Pharma LLC

·         Mankind Pharma Pte Limited

·         Superba Developers

 

 

Associate :

Penta Latex

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

·         A To Z Packers

·         A S Packers

·         Copmed Pharmaceuticals Private Limited, India [U74899DL1988PTC033151]

·         J. K. Printpack Mediforce Healthcare Private Limited, India [U51397up2001ptc025873]

·         N. S. Industries

·         Next Wave (India)

·         Pharma Force Lab Printman

·         Relax Pharmaceuticals Private Limited, India [U24231UP1997PTC022390]

·         Sirmour Remedies Private Limited, India [U15311HP1989PTC009770]

·         Anm Pharma Private Limited, India [U24233DL2013PTC262682]

·         Paonta Process  Equipment

·         Rashi Apparels Private Limited, India (U74899DL1991PTC043986)

·         Casablanca Securities Private Limited, India [U67120DL1996PTC078045]

·         Indu Buildwell Private Limited, India [U45201DL2005PTC132765]

·         Alankrit Handicrafts Private Limited, India (U99999DL1974PTC007499)

·         Superba Buildwell

·         Luxor Metaltec India Private Limited, India (U74899DL1976PTC008081)

·         Rashmi Exports Private Limited, India [U74899DL1991PTC043979]

·         Teen Murti Products Private Limited, India [U74899DL1991PTC045731]

·         Star Infra Developers Private Limited, India [U45400DL2010PTC205809]

·         Om Sai Pharma Pack

 

 

CAPITAL STRUCTURE

 

AFTER 30.09.2016

 

Authorised Capital : INR 410.000 Million

 

Issued, Subscribed & Paid-up Capital : INR 400.588 Million

 

 

AS ON 31.03.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

25000000

Equity Shares

INR 10/- each

INR 250.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20029422

Equity Shares

INR 10/- each

INR 200.294 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET [STANDALONE]

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

31.03.2014

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

200.294

200.294

200.294

(b) Reserves & Surplus

20465.575

19386.198

15354.723

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

20665.869

19586.492

15555.017

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

0.000

0.178

0.000

(b) Deferred tax liabilities (Net)

0.000

2.937

44.481

(c) Other long term liabilities

0.000

0.000

220.675

(d) long-term provisions

148.976

89.911

48.404

Total Non-current Liabilities (3)

148.976

93.026

313.560

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.340

(b) Trade payables

3266.691

2839.744

1757.908

(c) Other current liabilities

673.651

563.819

1088.350

(d) Short-term provisions

14.576

11.425

3094.169

Total Current Liabilities (4)

3954.918

3414.988

5940.767

 

 

 

 

TOTAL

24769.763

23094.506

21809.344

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

2414.540

2166.380

1953.742

(ii) Intangible Assets

61.130

49.084

73.135

(iii) Capital work-in-progress

765.694

419.923

202.646

(iv) Intangible assets under development

0.000

34.985

11.064

(b) Non-current Investments

3154.902

2560.060

1095.071

(c) Deferred tax assets (net)

12.598

0.000

0.000

(d)  Long-term Loan and Advances

5527.625

4009.420

1938.709

(e) Other Non-current assets

1.744

2.108

410.220

Total Non-Current Assets

11938.233

9241.960

5684.587

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

5331.642

6884.746

6890.536

(b) Inventories

4101.506

3985.663

3371.861

(c) Trade receivables

1573.879

1690.148

1316.920

(d) Cash and cash equivalents

718.069

405.901

999.576

(e) Short-term loans and advances

958.107

882.637

3545.864

(f) Other current assets

148.327

3.451

0.000

Total Current Assets

12831.530

13852.546

16124.757

 

 

 

 

TOTAL

24769.763

23094.506

21809.344

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

 

Revenue from Operations

31495.083

26824.364

22885.864

 

 

Other Income

727.317

733.378

436.086

 

 

TOTAL                                     (A)

32222.400

27557.742

23321.950

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

1289.844

1263.301

1129.821

 

 

Purchases of Stock-in-Trade

10886.390

10352.497

8664.162

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(125.983)

(764.393)

(156.570)

 

 

Employees benefits expense

5738.902

4809.367

3543.082

 

 

Other expenses

7270.964

5867.493

5005.766

 

 

CSR Expenditure

44.315

77.691

0.000

 

 

TOTAL                                     (B)

25104.432

21605.956

18186.261

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

7117.968

5951.786

5135.689

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

14.529

14.861

14.452

 

 

 

 

 

 

PROFIT/(LOSS)  BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

7103.439

5936.925

5121.237

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

366.966

356.409

265.472

 

 

 

 

 

 

PROFIT/(LOSS)  BEFORE TAX (E-F)                 (G)

6736.473

5580.516

4855.765

 

 

 

 

 

Less

TAX                                                                  (H)

2044.516

1545.145

1413.780

 

 

 

 

 

 

PROFIT/(LOSS)  AFTER TAX (G-H)                   (I)

4691.957

4035.371

3441.985

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings (FOB basis)

114.282

90.623

37.077

 

 

Earnings on dividend

330.486

0.000

0.000

 

TOTAL EARNINGS

444.768

90.623

37.077

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

0.000

0.169

96.607

 

 

Stores & Spares

9.783

4.254

57.674

 

 

Capital Goods

151.080

121.334

0.000

 

TOTAL IMPORTS

160.863

125.757

154.281

 

 

 

 

 

 

Earnings/(Loss)  Per Share (INR)

234.25

201.47

171.85

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

NA

NA

NA

 

 

 

 

Net cash flows from (used in) operations

7563.443

5498.118

9722.898

 

 

 

 

Net cash flows from (used in) operating activities

4825.400

3261.933

11189.237

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

(Sundry Debtors / Income * 365 Days)

18.24

23.00

21.00

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

20.01

15.87

17.38

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

97.92

89.23

65.51

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.74

1.49

1.52

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

2.20

2.23

2.29

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.16

0.15

0.27

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.00

0.00

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.19

0.17

0.38

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.16

0.14

0.14

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

489.91

400.50

355.36

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Net Profit Margin

((PAT / Sales) * 100)

%

14.90

15.04

15.04

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

18.94

17.47

15.78

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

22.70

20.60

22.13

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

3.24

4.06

2.71

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

2.21

2.89

2.15

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.83

0.85

0.71

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.00

0.00

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

3.24

4.06

2.71

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL DATA

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Share Capital

200.294

200.294

200.294

Reserves & Surplus

15354.723

19386.198

20465.575

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

15555.017

19586.492

20665.869

 

 

 

 

long-term borrowings

0.000

0.178

0.000

Short term borrowings

0.340

0.000

0.000

Total borrowings

0.340

0.178

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Sales

22885.864

26824.364

31495.083

 

 

17.209

17.412

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Sales

22885.864

26824.364

31495.083

Profit

3441.985

4035.371

4691.957

 

15.04%

15.04%

14.90%

 


ABRIDGED BALANCE SHEET [CONSOLIDATED]

 

SOURCES OF FUNDS

 

 

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

200.294

200.294

(b) Reserves & Surplus

 

21968.771

20347.470

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

(3) Minority Interest

 

296.632

155.747

Total Shareholders’ Funds (1) + (2)

 

22465.697

20703.511

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

 

23.994

0.178

(b) Deferred tax liabilities (Net)

 

3.546

4.335

(c) Other long term liabilities

 

100.188

160.151

(d) long-term provisions

 

192.600

127.171

Total Non-current Liabilities (3)

 

320.328

291.835

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

4221.168

3801.495

(c) Other current liabilities

 

906.819

520.953

(d) Short-term provisions

 

44.690

10.408

Total Current Liabilities (4)

 

5172.677

4332.856

 

 

 

 

TOTAL

 

27958.702

25328.202

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

3559.336

2717.349

(ii) Intangible Assets

 

61.130

49.293

(iii) Capital work-in-progress

 

1464.437

436.950

(iv) Intangible assets under development

 

0.000

35.048

(b) Non-current Investments

 

2053.122

2223.505

(c) Deferred tax assets (net)

 

31.430

11.496

(d)  Long-term Loan and Advances

 

3568.822

2726.526

(e) Other Non-current assets

 

922.459

399.982

Total Non-Current Assets

 

11660.736

8600.149

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

5963.971

7368.655

(b) Inventories

 

6191.090

5961.989

(c) Trade receivables

 

1927.078

1970.177

(d) Cash and cash equivalents

 

987.019

387.913

(e) Short-term loans and advances

 

1077.384

1035.798

(f) Other current assets

 

151.424

3.521

Total Current Assets

 

16297.966

16728.053

 

 

 

 

TOTAL

 

27958.702

25328.202

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

 

31.03.2016

31.03.2015

 

SALES

 

 

 

 

 

Revenue from Operations

 

39370.192

33231.400

 

 

Other Income

 

742.095

761.914

 

 

TOTAL                                    

 

40112.287

33993.314

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

 

1703.653

1452.209

 

 

Purchases of Stock-in-Trade

 

14109.618

13424.854

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(251.896)

(942.770)

 

 

Employees benefits expense

 

7376.070

6099.153

 

 

Other expenses

 

8940.980

7261.768

 

 

CSR Expenditure

 

54.315

82.991

 

 

TOTAL                                    

 

31932.740

27378.205

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

8179.547

6615.109

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

 

21.160

21.528

 

 

 

 

 

 

PROFIT/(LOSS)  BEFORE TAX, DEPRECIATION AND AMORTISATION

 

8158.387

6593.581

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

 

420.374

385.369

 

 

 

 

 

 

PROFIT/(LOSS)  BEFORE TAX

 

7738.013

6208.212

 

 

 

 

 

Less

TAX                                                                 

 

2425.443

1767.802

 

 

 

 

 

 

PROFIT (LOSS) FOR PERIOD BEFORE MINORITY INTEREST

 

5312.570

4440.410

 

 

 

 

 

Add

PROFIT (LOSS) OF MINORITY INTEREST

 

(91.083)

(58.670)

 

 

 

 

 

Add

SHARE OF PROFIT (LOSS) OF ASSOCIATES

 

18.161

11.314

 

 

 

 

 

 

PROFIT (LOSS) FOR PERIOD

 

5239.648

4393.054

 

 

 

 

 

 

Earnings/(Loss)  Per Share (INR)

 

261.60

219.33

 

 

 


 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

INDEX OF CHARGES

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

B92245323

10468043

DIRECTOR OF INDUSTRIES HIMACHAL PRADESH

04/12/2013

-

-

3000000.0

Single Window Clearance Agency, Paonta SahibDistrict SirmourPAONTA SAHIBHP173025IN

2

B14582340

10291096

DIRECTOR OF INDUSTRIES HIMACHAL PRADESH

07/06/2011

-

-

3000000.0

SINGLE WINDOW CLEARANCE AGAENCY , PONTA SAHIBDIST; SIRMOURPANTA SAHIBHP173025IN

3

G43878784

10248498

Citi Bank N.A.

12/10/2010

10/03/2017

-

1200000000.0

Jeevan Bharti Building, 4th Floor124 Connaught Circus, Connaught PlaceNew DelhiDL110001IN

4

C09791385

10143837

DIRECTOR OF INDUSTRIES, HIMACHAL PRADESH

16/01/2009

-

28/06/2014

3000000.0

THROUGH MEMBER SECRETARY,SINGLE WINDOW CLEARANCE AGENCY, PAONTA SAHIBSIRMOURHP173025IN

5

B30089601

10028667

ICICI BANK LIMITED

09/11/2006

04/03/2009

10/01/2012

31150000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

6

B30326342

10142492

ICICI BANK LIMITED

19/02/2009

-

10/01/2012

31150000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

7

B12224515

10043829

ICICI BANK LIMITED

12/02/2007

-

28/04/2011

83250000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

8

B11604162

10015497

ICICI BANK LIMITED

16/01/2006

-

28/04/2011

83250000.0

LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN

9

A00517219

90037809

STATE BANK OF PATIALA

18/01/2003

12/04/2006

01/01/2008

30000000.0

MEERUTMEERUTUP250002IN

 

 

CORPORATE INFORMATION

 

Mankind Pharma Limited (“hereinafter referred to the Company”) was incorporated on 3 July, 1991. The company is engaged in manufacturing and trading of pharmaceutical and health care products in India.

 

 

NATURE OF BUSINESS

 

During the year, the Company has not changed its nature of business. The Company continues to carry on business of manufacturing, marketing and trading of pharmaceutical products.

 

 

SUMMARY OF OPERATIONS

 

During the year, the total revenue (standalone) from operations of the Company increased from INR 27557.742 Million to INR 32222.400 Million with a growth of 16.92%. For FY 2015-16, the Company’s profit after tax stood at INR 4691.957 Million vis-à-vis INR 4035.371 Million in the previous year, registering a growth of 16.27%.

 

Whereas during the year, the consolidated net revenue from operations increased from INR 33993.314 Million to INR 40112.287 Million with a growth of 18% and Profit after tax was at INR 5239.648 Million, recording an increase of 19.27% over the previous year.

 

 

FIXED ASSETS:

 

Tangible Assets

 

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Computer Equipments

 

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

INR 63.50

UK Pound

1

INR 90.92

Euro

1

INR 79.07

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

VAR

 

 

Report Prepared by :

IND

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.